Yangnong Chemical announced that in the third quarter of 2026, the company produced 93450.01 tons of raw drugs and sold 90645.47 tons, achieving operating income of 5.837 billion yuan; formulation output was 25434.43 tons and sales volume was 28531.63 tons, achieving revenue of 1,257 billion yuan. From January to September 2026, the average sales price of the original drug was 64,400 yuan/ton, up 2.77% year on year; the average sales price of the preparation was 44,000 yuan/ton, up 10.62% year on year. Among the main raw materials, the average purchase price of sulfoxide chloride rose 117.27% year on year, hydrobromic acid rose 38.92% year on year, and liquid alkali decreased 20.22% year on year.

Yangnong Chemical announced that in the third quarter of 2026, the company produced 93450.01 tons of raw drugs and sold 90645.47 tons, achieving operating income of 5.837 billion yuan; formulation output was 25434.43 tons and sales volume was 28531.63 tons, achieving revenue of 1,257 billion yuan. From January to September 2026, the average sales price of the original drug was 64,400 yuan/ton, up 2.77% year on year; the average sales price of the preparation was 44,000 yuan/ton, up 10.62% year on year. Among the main raw materials, the average purchase price of sulfoxide chloride rose 117.27% year on year, hydrobromic acid rose 38.92% year on year, and liquid alkali decreased 20.22% year on year.